second generation

Obstetric Outcomes After Exposure to Second-Generation Long-Acting Injectable Antipsychotic Medications

Exposure to long-acting injectable and oral second-generation antipsychotics during pregnancy was associated with similar obstetric outcomes in a large retrospective study.

By Ruta Nonacs, MD PhD|2026-01-20T11:45:54-04:00January 13th, 2026|Pregnancy & Medications|Comments Off

Antipsychotics and Pregnancy Part 2: Preliminary Data from the MGH Pregnancy Registry

This is the second part of a two part series on the use of antipsychotic medications during pregnancy. Read Part 1 here, which reviews data from the Australian antipsychotic registry.

By MGH Center for Women's Mental Health|2016-03-28T13:23:55-04:00August 6th, 2014|Antipsychotic Medications, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off